WHO-CHOICE Interventions

Tuberculosis

SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS

50%

TB-3

SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR

SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS

80%

TB-7

SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR

SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS

95%

TB-11

SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR